These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2128429)

  • 1. Effect of administration of sodium aurothiomalate on the virulence of yellow fever viruses in adult mice.
    Gibson CA; Wills MR; Gould EA; Sanders PG; Barrett AD
    Vaccine; 1990 Dec; 8(6):590-4. PubMed ID: 2128429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus.
    Dunster LM; Wang H; Ryman KD; Miller BR; Watowich SJ; Minor PD; Barrett AD
    Virology; 1999 Sep; 261(2):309-18. PubMed ID: 10497116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of Live-Attenuated Yellow Fever 17D Vaccine Virus Is Localized to a High-Fidelity Replication Complex.
    Davis EH; Beck AS; Strother AE; Thompson JK; Widen SG; Higgs S; Wood TG; Barrett ADT
    mBio; 2019 Oct; 10(5):. PubMed ID: 31641088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of neurovirulence of different strains of yellow fever virus in mice.
    Barrett AD; Gould EA
    J Gen Virol; 1986 Apr; 67 ( Pt 4)():631-7. PubMed ID: 3958694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of wild-type yellow fever virus by passage in HeLa cells.
    Barrett AD; Monath TP; Cropp CB; Adkins JA; Ledger TN; Gould EA; Schlesinger JJ; Kinney RM; Trent DW
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2301-6. PubMed ID: 2230735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mouse model for studying viscerotropic disease caused by yellow fever virus infection.
    Meier KC; Gardner CL; Khoretonenko MV; Klimstra WB; Ryman KD
    PLoS Pathog; 2009 Oct; 5(10):e1000614. PubMed ID: 19816561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein.
    Schlesinger JJ; Brandriss MW; Monath TP
    Virology; 1983 Feb; 125(1):8-17. PubMed ID: 6187129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain.
    Thibodeaux BA; Garbino NC; Liss NM; Piper J; Blair CD; Roehrig JT
    Vaccine; 2012 May; 30(21):3180-7. PubMed ID: 22425792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Diversity Does Not Contribute to Attenuation of HeLa Passaged Wild-Type Yellow Fever Virus Strain French Viscerotropic Virus.
    Strother AE; Thompson JK; Widen SG; Barrett ADT
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis By Deep Sequencing of Discontinued Neurotropic Yellow Fever Vaccine Strains.
    Beck AS; Wood TG; Widen SG; Thompson JK; Barrett ADT
    Sci Rep; 2018 Sep; 8(1):13408. PubMed ID: 30194325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.
    Monath TP; Levenbook I; Soike K; Zhang ZX; Ratterree M; Draper K; Barrett AD; Nichols R; Weltzin R; Arroyo J; Guirakhoo F
    J Virol; 2000 Feb; 74(4):1742-51. PubMed ID: 10644345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infection.
    Lefeuvre A; Contamin H; Decelle T; Fournier C; Lang J; Deubel V; Marianneau P
    Microbes Infect; 2006 May; 8(6):1530-8. PubMed ID: 16697681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
    Brandriss MW; Schlesinger JJ; Walsh EE; Briselli M
    J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines.
    Monath TP; Arroyo J; Levenbook I; Zhang ZX; Catalan J; Draper K; Guirakhoo F
    J Virol; 2002 Feb; 76(4):1932-43. PubMed ID: 11799188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice.
    Ryman KD; Xie H; Ledger TN; Campbell GA; Barrett AD
    Virology; 1997 Apr; 230(2):376-80. PubMed ID: 9143294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the nucleotide and deduced amino acid sequences of the envelope protein genes of the wild-type French viscerotropic strain of yellow fever virus and the live vaccine strain, French neurotropic vaccine, derived from it.
    Jennings AD; Whitby JE; Minor PD; Barrett AD
    Virology; 1993 Feb; 192(2):692-5. PubMed ID: 8421909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus.
    Mateu GP; Marchevsky RS; Liprandi F; Bonaldo MC; Coutinho ES; Dieudonné M; Caride E; Jabor AV; Freire MS; Galler R
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):289-98. PubMed ID: 17169387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Japanese encephalitis virus/yellow fever virus chimera is safe and confers full protection against yellow fever virus in intracerebrally challenged mice.
    Yang H; Yang H; Li Z; Liu L; Wang W; He T; Fan F; Sun Y; Liu J; Li Y; Zeng X
    Vaccine; 2018 Apr; 36(18):2450-2455. PubMed ID: 29580643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.